Disclosure of Medical Business Information
Developing and manufacturing medical equipment such as endoscopes, Olympus and its Japan subsidiaries held an Ethics Committee meeting and assessed propriety from the points of view of ethics, science and reliability as well as conflicts of interest in its medical research to comply with the "Declaration of Helsinki (Ethical Principles for Medical Research Involving Human Subjects)" and the "Ethical Guidelines for Medical and Health Research Involving Human Subjects." We ensured the independence of the Committee by having it comprise internal and external experts not directly involved in the research.
The scope of the assessment was all of the medical research conducted by Japan subsidiaries to which the Ethical Guidelines for Medical and Health Research Involving Human Subjects applies. For greater transparency of the Ethics Committee, we disclose the Committee's rules, list of members and summary of proceedings by registration on the Ethical Review Committee Reporting System of the Ministry of Health, Labour and Welfare.
We started the online Ethics Committee meetings in FY2021 to minimize the impact of COVID-19 on our new and ongoing research activities.
Olympus and its Japan subsidiaries have established Transparency Guidelines for Relations between Olympus and Medical Institutions and other Organizations described below and are working to assure and increase transparency based on full disclosure of information on payments made to medical institutions and personnel in accordance with the Guidelines. The approximate amount of the financial grants given by the Olympus Group in FY2021 is US$5.3 million (equivalent to 586 million yen)